IMD-0560

• UNSPSC Description:

  IMD-0560 is a novel IκB kinase β inhibitor.

• Target Antigen:

  IKK

• Type:

  Reference compound

• Related Pathways:

  NF-κB

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/IMD-0560.html

• Purity:

  98.73

• Solubility:

  10 mM in DMSO|Ethanol : 50 mg/mL (ultrasonic)

• Smiles:

  O=C(C1=C(C=CC(Br)=C1)O)NC2=C(C=CC(C(F)(F)F)=C2)C(F)(F)F

• Molecular Weight:

  428.12

• References & Citations:

  [1]Tada Y, et al. The novel IκB kinase β inhibitor IMD-0560 prevents bone invasion by oral squamous cell carcinoma. Oncotarget. 2014 Dec 15;5(23):12317-30.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Clinical Information:

  No Development Reported

• CAS Number:

  439144-66-8